STAAR SURGICAL CO
For the period ended Jun 27, 2025. Filed Aug 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 27, 2025 · Filed Aug 6, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
The following table summarizes the Company’s share repurchase activity for the three months ended June 27, 2025, on a monthly basis:
| Period · Total Number of Shares (or Units) Purchased · Average Price Paid per Share (or Unit) · Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs · Maximum Number (or Approximate Dollar Value) of Shares that may yet to be Purchased Under the Plans or Programs (in thousands)(1) | |||||
|---|---|---|---|---|---|
| March 29 - April 25, 2025 | — | $— | — | $30,000 | |
| April 26 - May 23, 2025 | — | — | — | 30,000 | |
| May 24 - June 27, 2025 | 260,515 | 17.17 | 260,515 | 25,521 | |
| Total | 260,515 | 260,515 | |||
(1)
On May 16, 2025, the Company announced that its Board of Directors authorized a share repurchase program under which the Company may repurchase up to $30 million of its outstanding common stock. During the quarter ended June 27, 2025 the Company purchased 260,515 shares for an aggregate of $4.5 million. As of June 27, 2025, approximately $25.5 million remained available for repurchases pursuant to our share repurchase program. Under the share repurchase program, the Company may repurchase shares in the open market, through privately negotiated transactions, by entering into structured repurchase agreements with third parties, by making block purchases, and/or pursuant to Rule 10b5-1 trading plans. The timing, manner, price, and amount of any repurchases under the program will be determined by the Company in its discretion, subject to market conditions, legal requirements, and other considerations. The Company is not obligated to repurchase any specific number of shares, and the program may be modified, suspended, or discontinued at any time, without prior notice.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.